EPIDUO FORTE GEL Rx
Generic Name and Formulations:
Adapalene 0.3%, benzoyl peroxide 2.5%; gel.
Galderma Laboratories, Inc.
Indications for EPIDUO FORTE GEL:
Treatment of acne vulgaris.
Apply thin film to affected areas of face and/or trunk once daily after washing. Use a pea-sized amount for each area of the face (eg, forehead, chin, cheek). Reduce frequency or discontinue if prolonged or severe irritation occurs.
Do not use on cuts, abrasions, eczematous or sunburned skin. Avoid eyes, lips, mucous membranes, sun, UV light. Increased irritation in extreme weather. Pregnancy (Cat.C). Nursing mothers.
Retinoid + antibacterial/keratolytic.
Caution with other topical acne therapy (eg, peeling, desquamating, or abrasive agents). Avoid using concomitant topical irritants and waxing treated areas.
Dry skin, contact dermatitis, skin irritation, eczema; local reactions (eg, erythema, scaling, dryness, burning, stinging), may bleach fabrics or hair.
Adapalene: biliary. Benzoyl peroxide: renal.
Gel—45g (tube or pump); Forte Gel—15g, 30g, 45g, 60g, 70g pump
Endocrinology Advisor Articles
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Trends in Bisphosphonate Use and Hip Fracture Rates in Denmark
- Gender-Affirming Hormonal Treatment and Long-Term Bone Safety
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look
- FDA Committee Votes on Oral T1D Treatment Sotagliflozin
- Elevated Plasma Agouti-Related Protein May Be a Marker for Cushing Disease
- Therapeutic Effect of Long-Chain PUFA Omega 3 Supplementation in Obese Children
- Poor Health Outcomes Associated With Fear of Crime, Violence Among College Students of Color
- Safety of PCSK9 Inhibitors After Heart Transplantation Examined